Compare Stocks: CPHI, UTZ, UNCY, and LENZ

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CPHI China Pharma	$0.90	$1.13	$0.38 ▼ $19.19	$38.90M	1.05	1.83 million shs	121,529 shs
LENZ LENZ Therapeutics	$5.11	$5.29	$4.53 ▼ $50.40	$160.56M	0.65	736,993 shs	679,905 shs
UNCY Unicycive Therapeutics	$5.26 -0.2%	$5.60	$3.71 ▼ $8.74	$146.52M	1.79	728,352 shs	608,830 shs
UTZ Utz Brands	$14.21 +0.1%	$11.42	$6.78 ▼ $14.27	$2.05B	0.73	2.33 million shs	1.13 million shs

The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CPHI China Pharma	0.00%	-7.74%	-18.55%	+17.55%	-35.00%
LENZ LENZ Therapeutics	0.00%	+9.19%	-3.58%	-31.32%	-86.77%
UNCY Unicycive Therapeutics	0.00%	-6.57%	+4.99%	-30.79%	+25.54%
UTZ Utz Brands	0.00%	+0.57%	+0.60%	+96.68%	+6.00%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CPHI China Pharma	$0.90	$1.13	$0.38 ▼ $19.19	$38.90M	1.05	1.83 million shs	121,529 shs
LENZ LENZ Therapeutics	$5.11	$5.29	$4.53 ▼ $50.40	$160.56M	0.65	736,993 shs	679,905 shs
UNCY Unicycive Therapeutics	$5.26 -0.2%	$5.60	$3.71 ▼ $8.74	$146.52M	1.79	728,352 shs	608,830 shs
UTZ Utz Brands	$14.21 +0.1%	$11.42	$6.78 ▼ $14.27	$2.05B	0.73	2.33 million shs	1.13 million shs

The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CPHI China Pharma	0.00%	-7.74%	-18.55%	+17.55%	-35.00%
LENZ LENZ Therapeutics	0.00%	+9.19%	-3.58%	-31.32%	-86.77%
UNCY Unicycive Therapeutics	0.00%	-6.57%	+4.99%	-30.79%	+25.54%
UTZ Utz Brands	0.00%	+0.57%	+0.60%	+96.68%	+6.00%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CPHI China Pharma	0.00	N/A	N/A	N/A
LENZ LENZ Therapeutics	2.50	Moderate Buy	$28.80	463.60% Upside
UNCY Unicycive Therapeutics	2.57	Moderate Buy	$18.75	256.46% Upside
UTZ Utz Brands	2.00	Hold	$13.39	-5.80% Downside

Current Analyst Ratings Breakdown

Latest CPHI, UTZ, UNCY, and LENZ Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/25/2026	LENZ LENZ Therapeutics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
8/20/2026	UNCY Unicycive Therapeutics	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Speculative Buy	$13.00 ➝ $15.00
8/19/2026	UNCY Unicycive Therapeutics	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
8/13/2026	UNCY Unicycive Therapeutics	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$37.00 ➝ $25.00
8/13/2026	LENZ LENZ Therapeutics	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
8/12/2026	UNCY Unicycive Therapeutics	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$22.00 ➝ $20.00
8/12/2026	LENZ LENZ Therapeutics	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Neutral	$12.00 ➝ $7.00
8/12/2026	LENZ LENZ Therapeutics	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
8/11/2026	LENZ LENZ Therapeutics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
7/27/2026	UTZ Utz Brands	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy ➝ Hold
7/23/2026	UTZ Utz Brands	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Overweight ➝ Neutral	$10.00 ➝ $14.25

(Data available from 8/31/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CPHI China Pharma	$3.91M	9.94	N/A	N/A	$0.70 per share	1.29
LENZ LENZ Therapeutics	$21.48M	7.48	N/A	N/A	$9.09 per share	0.56
UNCY Unicycive Therapeutics	N/A	N/A	N/A	N/A	$1.41 per share	N/A
UTZ Utz Brands	$1.44B	1.42	$1.41 per share	10.10	$9.41 per share	1.51

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CPHI China Pharma	-$3.08M	-$0.43	N/A	N/A	N/A	-85.56%	-63.93%	-31.42%	N/A
LENZ LENZ Therapeutics	-$82.13M	-$4.09	N/A	N/A	N/A	-586.74%	-53.39%	-49.14%	11/4/2026 (Estimated)
UNCY Unicycive Therapeutics	-$26.56M	-$1.75	N/A	2.44	N/A	N/A	-91.50%	-61.47%	11/11/2026 (Estimated)
UTZ Utz Brands	$800K	-$0.33	N/A	16.52	N/A	-2.00%	8.97%	4.32%	10/29/2026 (Estimated)

Latest CPHI, UTZ, UNCY, and LENZ Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/12/2026	Q2 2026	UNCY Unicycive Therapeutics	-$0.4710	-$0.06	+$0.4110	-$0.06	$22.22 million	N/A
8/11/2026	Q2 2026	LENZ LENZ Therapeutics	-$1.05	-$1.02	+$0.03	-$1.02	$2.38 million	$5.49 million
8/5/2026	Q2 2026	UTZ Utz Brands	$0.1847	$0.19	+$0.0053	-$0.11	$374.18 million	$371.80 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
CPHI China Pharma	N/A	N/A	N/A	N/A	N/A
LENZ LENZ Therapeutics	N/A	N/A	N/A	N/A	N/A
UNCY Unicycive Therapeutics	N/A	N/A	N/A	N/A	N/A
UTZ Utz Brands	$0.25	1.76%	+18.77%	N/A	3 Years

Latest CPHI, UTZ, UNCY, and LENZ Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
6/11/2026	UTZ Utz Brands	quarterly	$0.0630	3.69%	6/22/2026	6/22/2026	7/2/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CPHI China Pharma	0.22	0.79	0.26
LENZ LENZ Therapeutics	N/A	13.55	13.31
UNCY Unicycive Therapeutics	N/A	3.81	3.81
UTZ Utz Brands	0.62	1.06	0.69

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CPHI China Pharma	N/A
LENZ LENZ Therapeutics	54.32%
UNCY Unicycive Therapeutics	40.42%
UTZ Utz Brands	95.97%

Insider Ownership

Company	Insider Ownership
CPHI China Pharma	6.40%
LENZ LENZ Therapeutics	8.30%
UNCY Unicycive Therapeutics	6.03%
UTZ Utz Brands	12.73%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CPHI China Pharma	250	43.02 million	15.92 million	Not Optionable
LENZ LENZ Therapeutics	110	31.42 million	28.81 million	N/A
UNCY Unicycive Therapeutics	9	27.86 million	26.18 million	Not Optionable
UTZ Utz Brands	3,300	143.96 million	125.64 million	Optionable

CPHI, UTZ, UNCY, and LENZ Headlines

Recent News About These Companies

12 Utz pretzels, ranked

August 29 at 4:56 PM | msn.com

Investor Notice: The Utz Brands (NYSE:UTZ) $14.25 Transaction is Being Investigated by BFA Law on behalf of Current Shareholders

August 28 at 6:46 AM | globenewswire.com

138,670 Shares in Utz Brands, Inc. $UTZ Purchased by Ancora Advisors LLC

August 28 at 3:12 AM | marketbeat.com

Bank of America Corp DE Buys 167,958 Shares of Utz Brands, Inc. $UTZ

August 27, 2026 | marketbeat.com

UTZ Securities Notice: Think the $14.25 Offer Price for Utz Brands is Unfair? BFA Law Notifies Shareholders of the Ongoing Investigation into the Potential Transaction

August 26, 2026 | globenewswire.com

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Stockholders of an Investigation into the Fairness of the Acquisition of Utz Brands, Inc.

August 25, 2026 | prnewswire.com

1 consumer stock for long-term investors and 2 we question

August 25, 2026 | msn.com

Utz Brands (NYSE:UTZ) Reaches New 52-Week High - Still a Buy?

August 25, 2026 | marketbeat.com

Class Action Lawsuit Filed Against Utz Brands Over 'Avocado Oil' Boulder Canyon Potato Chips, Citing UC Davis Study on Avocado Oil Authenticity Testing

August 24, 2026 | finance.yahoo.com

UTZ BUYOUT ALERT: Kaskela Law Firm Announces Investigation into Price Adequacy and Fairness of the Proposed $14.25 Per Share Cash Buyout Price – UTZ

August 24, 2026 | globenewswire.com

Investor Reminder: Utz Brands (NYSE:UTZ) Investors are Encouraged to Contact BFA Law – Investigation into Upcoming $14.25 Transaction Pending

August 24, 2026 | globenewswire.com

Utz Brands, Inc. (NYSE:UTZ) Receives Average Recommendation of "Hold" from Analysts

August 22, 2026 | americanbankingnews.com

UTZ Ongoing Investigation: BFA Law Notifies Utz Brands Shareholders that it is Investigating the $14.25 per share Transaction with Intersnack Group

August 21, 2026 | globenewswire.com

Utz Brands Sued for Alleged Deceptive Avocado Oil Ingredient Label On Chips

August 19, 2026 | finance.yahoo.com

Utz Brands (NYSE:UTZ) Reaches New 12-Month High - Here's What Happened

August 19, 2026 | marketbeat.com

UTZ Investor Reminder: Utz Brands Investigation over $14.25 per share Transaction is Ongoing – Contact BFA Law if You Hold Shares

August 19, 2026 | globenewswire.com

Are UTZ, ITGR, ACA, D Obtaining Fair Deals for their Shareholders?

August 18, 2026 | prnewswire.com

UTZ Investigation News: Utz Brands Investigation Initiated After $14.25 per share Acquisition Announced – Contact BFA Law if You Hold Shares

August 17, 2026 | globenewswire.com

Utz Brands, Inc. (NYSE:UTZ) Given Consensus Recommendation of "Hold" by Analysts

August 17, 2026 | marketbeat.com

1,878,175 Shares in Utz Brands, Inc. $UTZ Acquired by Diamond Hill Capital Management LLC Investment Advisor

August 17, 2026 | marketbeat.com

Utz sued for alleged deceptive avocado oil ingredient label on chips

August 15, 2026 | msn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

CPHI, UTZ, UNCY, and LENZ Company Descriptions

China Pharma NYSE:CPHI

$0.90 0.00 (0.00%)

As of 08/28/2026 04:00 PM Eastern

China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate injection to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Ozagrel Sodium to treat acute thrombotic cerebral infarction and dyskinesia; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide injection to treat edema diseases; and Candesartan for hypertension. In addition, the company provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Andrographolide for sore throat caused by upper respiratory tract infection; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. Further it offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Additionally, the company provides Vitamin B6 injection; Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors; Noni Enzyme, a food supplement; sanitizers; and masks. It offers its products through distributors, its network of sales offices, and sales representatives. The company is based in Haikou, the People's Republic of China.

LENZ Therapeutics NASDAQ:LENZ

$5.11 0.00 (0.00%)

As of 08/28/2026 04:00 PM Eastern

LENZ Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies to improve vision in the United States. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. The company is headquartered in Del Mar, California.

Unicycive Therapeutics NASDAQ:UNCY

$5.26 -0.01 (-0.19%)

As of 08/28/2026 04:00 PM Eastern

Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease on dialysis; and UNI 494, which is in Phase 1 clinical trials for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Altos, California.

Utz Brands NYSE:UTZ

$14.21 +0.01 (+0.07%)

As of 08/28/2026 03:58 PM Eastern

Utz Brands, Inc. engages in manufacture, marketing, and distribution of snack foods. It offers a range of salty snacks, including salty snacks, including potato chips, tortilla chips, pretzels, cheese snacks, pork skins, veggie snacks, pub/party mixes, tortilla chips, salsa and dips, ready-to-eat popcorn, and other snacks under the Utz, Zapp's, ON THE BORDER, Golden Flake, Boulder Canyon, Hawaiian, TORTIYAHS!, etc. The company sells its products to wholesale and other distributors, grocery stores, convenience and drug stores, discount stores, mass merchandisers, membership club stores, hard discounters, and specialty and e-commerce retailers. Utz Brands, Inc. was founded in 1921 and is headquartered in Hanover, Pennsylvania.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest CPHI, UTZ, UNCY, and LENZ Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest CPHI, UTZ, UNCY, and LENZ Earnings

Compare Dividends

Latest CPHI, UTZ, UNCY, and LENZ Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

CPHI, UTZ, UNCY, and LENZ Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

CPHI, UTZ, UNCY, and LENZ Company Descriptions

China Pharma NYSE:CPHI

LENZ Therapeutics NASDAQ:LENZ

Unicycive Therapeutics NASDAQ:UNCY

Utz Brands NYSE:UTZ

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest CPHI, UTZ, UNCY, and LENZ Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest CPHI, UTZ, UNCY, and LENZ Earnings

Compare Dividends

Latest CPHI, UTZ, UNCY, and LENZ Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

CPHI, UTZ, UNCY, and LENZ Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

CPHI, UTZ, UNCY, and LENZ Company Descriptions

China Pharma NYSE:CPHI

LENZ Therapeutics NASDAQ:LENZ

Unicycive Therapeutics NASDAQ:UNCY

Utz Brands NYSE:UTZ

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools